<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pharma Commons</title>
	<atom:link href="http://pharmacommons.org/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmacommons.org</link>
	<description></description>
	<lastBuildDate>Wed, 22 May 2013 16:37:00 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
		<item>
		<title>Daiichi Sankyo says it was misled over Ranbaxy probes</title>
		<link>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/awCM5N6J63A/story01.htm</link>
		<comments>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/awCM5N6J63A/story01.htm#comments</comments>
		<pubDate>Wed, 22 May 2013 16:37:00 +0000</pubDate>
		<dc:creator>Reuters: Healthcare</dc:creator>
				<category><![CDATA[Daiichi Sankyo]]></category>
		<category><![CDATA[daiichi sankyo]]></category>
		<category><![CDATA[hellip]]></category>
		<category><![CDATA[ranbaxy laboratories]]></category>

		<guid isPermaLink="false">http://pharmacommons.org/?guid=80fc44a72b3ab36d178730b676a856aa</guid>
		<description><![CDATA[MUMBAI, May 22 (Reuters) - Japanese drugmaker Daiichi Sankyo Co, which bought control of Ranbaxy Laboratories in 2008, said it believes unnamed former shareholders of the Indian company hid informatio&#8230;]]></description>
			<content:encoded><![CDATA[MUMBAI, May 22 (Reuters) - Japanese drugmaker Daiichi Sankyo Co, which bought control of Ranbaxy Laboratories in 2008, said it believes unnamed former shareholders of the Indian company hid informatio&hellip;]]></content:encoded>
			<wfw:commentRss>http://pharmacommons.org/daiichi-sankyo/daiichi-sankyo-says-it-was-misled-over-ranbaxy-probes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Billionaires snap up former Merck Serono HQ for Geneva biotech hotspot</title>
		<link>http://www.fiercepharma.com/story/billionaires-snap-former-merck-serono-hq-geneva-biotech-hotspot/2013-05-22?utm_source=rss&#038;utm_medium=rss</link>
		<comments>http://www.fiercepharma.com/story/billionaires-snap-former-merck-serono-hq-geneva-biotech-hotspot/2013-05-22?utm_source=rss&#038;utm_medium=rss#comments</comments>
		<pubDate>Wed, 22 May 2013 15:42:06 +0000</pubDate>
		<dc:creator>FiercePharma News</dc:creator>
				<category><![CDATA[Merck]]></category>
		<category><![CDATA[ernesto bertarelli]]></category>
		<category><![CDATA[merck serono]]></category>
		<category><![CDATA[Wyss]]></category>

		<guid isPermaLink="false">http://pharmacommons.org/?guid=c80b754f3ec9db2349d5f1609ac5f30c</guid>
		<description><![CDATA[Two Swiss billionaires--Ernesto Bertarelli and Hansj&#246;rg Wyss--have joined forces to buy out the former&#160;Merck Serono&#160;facility in Geneva.]]></description>
			<content:encoded><![CDATA[Two Swiss billionaires--Ernesto Bertarelli and Hansj&ouml;rg Wyss--have joined forces to buy out the former&nbsp;Merck Serono&nbsp;facility in Geneva.]]></content:encoded>
			<wfw:commentRss>http://pharmacommons.org/merck/billionaires-snap-up-former-merck-serono-hq-for-geneva-biotech-hotspot/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Swiss billionaires create major biotech campus at former Serono site</title>
		<link>http://www.fiercebiotech.com/story/swiss-billionaires-create-major-biotech-campus-former-serono-site/2013-05-22?utm_source=rss&#038;utm_medium=rss</link>
		<comments>http://www.fiercebiotech.com/story/swiss-billionaires-create-major-biotech-campus-former-serono-site/2013-05-22?utm_source=rss&#038;utm_medium=rss#comments</comments>
		<pubDate>Wed, 22 May 2013 15:16:36 +0000</pubDate>
		<dc:creator>FierceBiotech News</dc:creator>
				<category><![CDATA[EMD Serono]]></category>
		<category><![CDATA[ambitious plans]]></category>
		<category><![CDATA[ernesto bertarelli]]></category>
		<category><![CDATA[merck serono]]></category>

		<guid isPermaLink="false">http://pharmacommons.org/?guid=9188f10be63c60c40b6b3d040f0a099d</guid>
		<description><![CDATA[Two Swiss billionaires--Ernesto Bertarelli and Hansjorg Wyss--have joined forces to buy out the former Merck Serono facility in Geneva, with ambitious plans to create a major collaboration on discover&#8230;]]></description>
			<content:encoded><![CDATA[Two Swiss billionaires--Ernesto Bertarelli and Hansjorg Wyss--have joined forces to buy out the former Merck Serono facility in Geneva, with ambitious plans to create a major collaboration on discover&hellip;]]></content:encoded>
			<wfw:commentRss>http://pharmacommons.org/emd-serono/swiss-billionaires-create-major-biotech-campus-at-former-serono-site/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GSK signs $200 million antibiotics pact with US govt</title>
		<link>http://pharmatimes.com/Article/13-05-22/GSK_signs_200_million_antibiotics_pact_with_US_govt.aspx</link>
		<comments>http://pharmatimes.com/Article/13-05-22/GSK_signs_200_million_antibiotics_pact_with_US_govt.aspx#comments</comments>
		<pubDate>Wed, 22 May 2013 14:08:00 +0000</pubDate>
		<dc:creator>PharmaTimes World News</dc:creator>
				<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[antibiotics]]></category>
		<category><![CDATA[gsk]]></category>
		<category><![CDATA[pact]]></category>

		<guid isPermaLink="false">http://pharmacommons.org/?guid=7a62e66cbbe544d7b0edb2e2ced90dbb</guid>
		<description><![CDATA[GSK signs $200 million antibiotics pact with US govt&#8230;]]></description>
			<content:encoded><![CDATA[GSK signs $200 million antibiotics pact with US govt&hellip;]]></content:encoded>
			<wfw:commentRss>http://pharmacommons.org/glaxosmithkline/gsk-signs-200-million-antibiotics-pact-with-us-govt/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>GlaxoSmithKline wins up to $200M federal contract to develop new antibiotics</title>
		<link>http://www.fiercebiotech.com/story/glaxosmithkline-wins-200m-federal-contract-develop-new-antibiotics/2013-05-22?utm_source=rss&#038;utm_medium=rss</link>
		<comments>http://www.fiercebiotech.com/story/glaxosmithkline-wins-200m-federal-contract-develop-new-antibiotics/2013-05-22?utm_source=rss&#038;utm_medium=rss#comments</comments>
		<pubDate>Wed, 22 May 2013 14:02:40 +0000</pubDate>
		<dc:creator>FierceBiotech News</dc:creator>
				<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[federal contract]]></category>
		<category><![CDATA[new antibiotics]]></category>
		<category><![CDATA[u s department of health and human services]]></category>

		<guid isPermaLink="false">http://pharmacommons.org/?guid=e2d02820f1b4389073f7544bd87fccdb</guid>
		<description><![CDATA[In the first collaboration of its kind, the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority has brought on GlaxoSmithKline to help the federal agen&#8230;]]></description>
			<content:encoded><![CDATA[In the first collaboration of its kind, the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority has brought on GlaxoSmithKline to help the federal agen&hellip;]]></content:encoded>
			<wfw:commentRss>http://pharmacommons.org/glaxosmithkline/glaxosmithkline-wins-up-to-200m-federal-contract-to-develop-new-antibiotics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Swiss billionaires buy Merck Serono HQ for biotech campus</title>
		<link>http://feeds.reuters.com/~r/reuters/healthNews/~3/i8HdzuA-I0A/story01.htm</link>
		<comments>http://feeds.reuters.com/~r/reuters/healthNews/~3/i8HdzuA-I0A/story01.htm#comments</comments>
		<pubDate>Wed, 22 May 2013 13:53:57 +0000</pubDate>
		<dc:creator>Reuters: Health News</dc:creator>
				<category><![CDATA[Merck]]></category>
		<category><![CDATA[ernesto bertarelli]]></category>
		<category><![CDATA[geneva headquarters]]></category>
		<category><![CDATA[merck serono]]></category>

		<guid isPermaLink="false">http://pharmacommons.org/?guid=73dc4207229cad4d4f972904f06b68f1</guid>
		<description><![CDATA[ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus.]]></description>
			<content:encoded><![CDATA[ZURICH (Reuters) - Swiss billionaire Ernesto Bertarelli has bought back the Geneva headquarters of his former biotech firm Serono, hoping to establish a biotech research campus.]]></content:encoded>
			<wfw:commentRss>http://pharmacommons.org/merck/swiss-billionaires-buy-merck-serono-hq-for-biotech-campus/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Canada approves Life Technologies&#8217; Dx sequencing devices</title>
		<link>http://www.smartbrief.com/servlet/rdrc?u=/news/storyDetails.jsp?issueid=D48FAF82-8E1A-4FBC-9CBC-23EA80FF3938&#038;copyid=F245CB49-9646-4C8D-8CA6-BE832C7DE9C5&#038;brief=bio&#038;sb_code=rss&#038;&#038;campaign=rss</link>
		<comments>http://www.smartbrief.com/servlet/rdrc?u=/news/storyDetails.jsp?issueid=D48FAF82-8E1A-4FBC-9CBC-23EA80FF3938&#038;copyid=F245CB49-9646-4C8D-8CA6-BE832C7DE9C5&#038;brief=bio&#038;sb_code=rss&#038;&#038;campaign=rss#comments</comments>
		<pubDate>Wed, 22 May 2013 13:48:39 +0000</pubDate>
		<dc:creator>BIO SmartBrief</dc:creator>
				<category><![CDATA[Life Technologies]]></category>
		<category><![CDATA[applied biosystems]]></category>
		<category><![CDATA[hellip]]></category>
		<category><![CDATA[nbsp]]></category>

		<guid isPermaLink="false">http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DD48FAF82-8E1A-4FBC-9CBC-23EA80FF3938%26copyid%3DF245CB49-9646-4C8D-8CA6-BE832C7DE9C5%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid>
		<description><![CDATA[Life Technologies has received approval in Canada for its Applied Biosystems 3500 Dx Series Genetic Analyzers to be used in d&#160;-More-&#160;&#8230;]]></description>
			<content:encoded><![CDATA[Life Technologies has received approval in Canada for its Applied Biosystems 3500 Dx Series Genetic Analyzers to be used in d&nbsp;-More-&nbsp;&hellip;]]></content:encoded>
			<wfw:commentRss>http://pharmacommons.org/life-technologies/canada-approves-life-technologies-dx-sequencing-devices/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Biogen submits MS drug candidate Plegridy for FDA approval</title>
		<link>http://www.smartbrief.com/servlet/rdrc?u=/news/storyDetails.jsp?issueid=D48FAF82-8E1A-4FBC-9CBC-23EA80FF3938&#038;copyid=74AB98E6-1D41-4CB9-B5CA-66BD3928CDB1&#038;brief=bio&#038;sb_code=rss&#038;&#038;campaign=rss</link>
		<comments>http://www.smartbrief.com/servlet/rdrc?u=/news/storyDetails.jsp?issueid=D48FAF82-8E1A-4FBC-9CBC-23EA80FF3938&#038;copyid=74AB98E6-1D41-4CB9-B5CA-66BD3928CDB1&#038;brief=bio&#038;sb_code=rss&#038;&#038;campaign=rss#comments</comments>
		<pubDate>Wed, 22 May 2013 13:48:39 +0000</pubDate>
		<dc:creator>BIO SmartBrief</dc:creator>
				<category><![CDATA[Biogen Idec]]></category>
		<category><![CDATA[biogen idec]]></category>
		<category><![CDATA[biologics license application]]></category>
		<category><![CDATA[ms drug]]></category>

		<guid isPermaLink="false">http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DD48FAF82-8E1A-4FBC-9CBC-23EA80FF3938%26copyid%3D74AB98E6-1D41-4CB9-B5CA-66BD3928CDB1%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid>
		<description><![CDATA[Biogen Idec has filed a biologics license application with the FDA for approval to use its interferon-based drug Plegridy as &#160;-More-&#160;&#8230;]]></description>
			<content:encoded><![CDATA[Biogen Idec has filed a biologics license application with the FDA for approval to use its interferon-based drug Plegridy as &nbsp;-More-&nbsp;&hellip;]]></content:encoded>
			<wfw:commentRss>http://pharmacommons.org/biogen-idec/biogen-submits-ms-drug-candidate-plegridy-for-fda-approval/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Regeneron-Sanofi&#8217;s asthma drug dupilumab shows promise in trial</title>
		<link>http://www.smartbrief.com/servlet/rdrc?u=/news/storyDetails.jsp?issueid=D48FAF82-8E1A-4FBC-9CBC-23EA80FF3938&#038;copyid=DF7EBBDB-6FD7-48B9-BA38-3463281BB577&#038;brief=bio&#038;sb_code=rss&#038;&#038;campaign=rss</link>
		<comments>http://www.smartbrief.com/servlet/rdrc?u=/news/storyDetails.jsp?issueid=D48FAF82-8E1A-4FBC-9CBC-23EA80FF3938&#038;copyid=DF7EBBDB-6FD7-48B9-BA38-3463281BB577&#038;brief=bio&#038;sb_code=rss&#038;&#038;campaign=rss#comments</comments>
		<pubDate>Wed, 22 May 2013 13:48:39 +0000</pubDate>
		<dc:creator>BIO SmartBrief</dc:creator>
				<category><![CDATA[Sanofi]]></category>
		<category><![CDATA[asthma attacks]]></category>
		<category><![CDATA[asthma drug]]></category>
		<category><![CDATA[regeneron]]></category>

		<guid isPermaLink="false">http://www.smartbrief.com/servlet/rdrc?u=%2Fnews%2FstoryDetails.jsp%3Fissueid%3DD48FAF82-8E1A-4FBC-9CBC-23EA80FF3938%26copyid%3DDF7EBBDB-6FD7-48B9-BA38-3463281BB577%26brief%3Dbio%26sb_code%3Drss%26%26campaign%3Drss</guid>
		<description><![CDATA[Regeneron Pharmaceuticals and Sanofi's experimental injectable drug dupilumab reduced asthma attacks by 87% during a Phase II&#160;-More-&#160;Stop banking and start building with GE Capital, Healthca&#8230;]]></description>
			<content:encoded><![CDATA[Regeneron Pharmaceuticals and Sanofi's experimental injectable drug dupilumab reduced asthma attacks by 87% during a Phase II&nbsp;-More-&nbsp;Stop banking and start building with GE Capital, Healthca&hellip;]]></content:encoded>
			<wfw:commentRss>http://pharmacommons.org/sanofi/regeneron-sanofis-asthma-drug-dupilumab-shows-promise-in-trial/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Swiss billionaires buy Merck Serono HQ for biotech campus</title>
		<link>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/PbfmlDSmopM/story01.htm</link>
		<comments>http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/PbfmlDSmopM/story01.htm#comments</comments>
		<pubDate>Wed, 22 May 2013 13:38:27 +0000</pubDate>
		<dc:creator>Reuters: Healthcare</dc:creator>
				<category><![CDATA[Merck]]></category>
		<category><![CDATA[hq]]></category>
		<category><![CDATA[merck serono]]></category>

		<guid isPermaLink="false">http://pharmacommons.org/?guid=62824f0f15422adc6504eda393a831bc</guid>
		<description><![CDATA[* Merck to sell Geneva site to Bertarelli-backed consortium&#8230;]]></description>
			<content:encoded><![CDATA[* Merck to sell Geneva site to Bertarelli-backed consortium&hellip;]]></content:encoded>
			<wfw:commentRss>http://pharmacommons.org/merck/swiss-billionaires-buy-merck-serono-hq-for-biotech-campus-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
